David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
PUT
Mettler-Toledo International
MTD
$28B
| $3.29M | 0.01% |
10,000
| – | – |
|
1652
Vanda Pharmaceuticals
VNDA
$323M
| $3.28M | 0.01% |
352,781
-16,490
| -4% | -$186K |
|
|
AHT
1653
Ashford Hospitality Trust
AHT
$21.6M
| $3.27M | 0.01% |
344
+109
| +46% | +$1.11M |
|
|
LMNX
1654
DELISTED
Luminex Corp
LMNX
| $3.25M | 0.01% |
203,440
+149,382
| +276% | +$2.51M |
|
1655
Titan International
TWI
$455M
| $3.25M | 0.01% |
347,549
-82,794
| -19% | -$805K |
|
1656
PUT
Allstate
ALL
$66.2B
| $3.25M | 0.01% |
45,700
-99,400
| -69% | -$7.02M |
|
1657
Target
TGT
$74.5B
| $3.24M | 0.01% |
+39,517
| New | +$3.05M |
|
1658
Ribbon Communications
RBBN
$363M
| $3.24M | 0.01% |
411,146
+113,729
| +38% | +$1.87M |
|
1659
CALL
Core Laboratories
CLB
$550M
| $3.24M | 0.01% |
31,000
+20,800
| +204% | +$2.22M |
|
|
PGI
1660
DELISTED
PREMIERE GLOBAL SERVICES, INC.
PGI
| $3.24M | 0.01% |
338,676
+81,082
| +31% | +$773K |
|
1661
Steel Dynamics
STLD
$33.8B
| $3.23M | 0.01% |
160,833
-101,246
| -39% | -$1.89M |
|
1662
Comstock Resources
CRK
$4.26B
| $3.23M | ﹤0.01% |
180,723
+15,252
| +9% | +$377K |
|
1663
QuidelOrtho
QDEL
$1.02B
| $3.22M | ﹤0.01% |
119,514
+50,483
| +73% | +$1.29M |
|
1664
PUT
Bunge Global
BG
$21.8B
| $3.22M | ﹤0.01% |
39,100
-80,100
| -67% | -$6.84M |
|
|
QGENF
1665
DELISTED
QIAGEN NV
QGENF
| $3.22M | ﹤0.01% |
127,588
-89,761
| -41% | -$2.26M |
|
1666
VF Corp
VFC
$5.46B
| $3.21M | ﹤0.01% |
+45,330
| New | +$3.14M |
|
1667
Radian Group
RDN
$4.87B
| $3.2M | ﹤0.01% |
190,812
-585,209
| -75% | -$9.54M |
|
|
IMOS
1668
ChipMOS TECHNOLOGIES
IMOS
$1.99B
| $3.19M | ﹤0.01% |
117,595
+8,147
| +7% | +$212K |
|
1669
CALL
Akamai
AKAM
$15.5B
| $3.19M | ﹤0.01% |
44,900
+10,000
| +29% | +$661K |
|
|
BBBY
1670
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
| $3.19M | ﹤0.01% |
41,500
-234,900
| -85% | -$17.8M |
|
1671
Spectrum Brands
SPB
$2.04B
| $3.16M | ﹤0.01% |
+35,278
| New | +$3.29M |
|
1672
CALL
Capital One
COF
$133B
| $3.15M | ﹤0.01% |
40,000
-56,000
| -58% | -$4.4M |
|
1673
PUT
Salesforce
CRM
$168B
| $3.15M | ﹤0.01% |
47,200
-383,700
| -89% | -$23.8M |
|
1674
PUT
Duke Energy
DUK
$95B
| $3.15M | ﹤0.01% |
41,000
-81,100
| -66% | -$6.58M |
|
|
VSTO
1675
DELISTED
Vista Outdoor Inc.
VSTO
| $3.15M | ﹤0.01% |
+73,517
| New | +$3.12M |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.